Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4542793 | 5706637 | F | 4542793-9 | 20041110 | 20041118 | 20041231 | EXP | PHBS2004JP15662 | NOVARTIS PHARMACEUTICALS CORP. | 11 | YR | F | Y | 33 | KG | 20041230 | MD |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4542793 | 1005547063 | PS | ZADITEN | 1 | ORAL | 2 MG/DAY | |||||
| 4542793 | 1005547064 | SS | CEFZON | 2 | ORAL | 300 IU/ML, UNK | |||||
| 4542793 | 1005547065 | SS | BIOFERMIN R | 2 | ORAL | 3 G, UNK |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4542793 | 1005547063 | ECZEMA |
| 4542793 | 1005547064 | WOUND INFECTION |
| 4542793 | 1005547065 | DIARRHOEA |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4542793 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 4542793 | BLOOD ALKALINE PHOSPHATASE INCREASED |
| 4542793 | BLOOD IMMUNOGLOBULIN E INCREASED |
| 4542793 | BLOOD LACTATE DEHYDROGENASE INCREASED |
| 4542793 | DRUG ERUPTION |
| 4542793 | EOSINOPHIL COUNT INCREASED |
| 4542793 | ERYTHEMA MULTIFORME |
| 4542793 | PRURITUS |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4542793 | HP |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 4542793 | 1005547063 | 20041106 | 20041110 | 7200 | MIN |
| 4542793 | 1005547064 | 20041106 | 20041110 | 7200 | MIN |
| 4542793 | 1005547065 | 20041106 | 20041110 | 7200 | MIN |